NCT06639828 - Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

October 31, 2026

Conditions

Focal Liver Lesions

Interventions

DIAGNOSTIC_TEST

Contrast-Enhanced Ultrasound

Following unenhanced (pre-contrast) ultrasound imaging of the target focal liver lesions (FLL), Sonazoid™ will be intravenously administered and a contrast-enhanced examination will be performed.

Trial Locations (6)

16147

NOT_YET_RECRUITING

Giannina Gaslini Institute, Genoa

24127

NOT_YET_RECRUITING

Papa Giovanni XXIII Hospital, Bergamo

81377

NOT_YET_RECRUITING

Munich University Hospital, München

BS2 8BJ

NOT_YET_RECRUITING

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol

SE5 9RS

RECRUITING

King's College Hospital NHS Foundation Trust, London

W2 1NY

RECRUITING

Imperial College Healthcare NHS Trust, London